International society of liquid biopsy (ISLB) perspective on minimal requirements for ctDNA testing in solid tumors

Circulating tumor DNA (ctDNA) testing has transformed precision oncology by enabling the non-invasive detection of actionable mutations. To facilitate broader clinical adoption and improve testing accuracy, standardized quality criteria must be clearly defined and universally implemented. The Intern...

Full description

Bibliographic Details

Published in:	The Journal of Liquid Biopsy
Main Authors:	Nicola Fusco, Konstantinos Venetis, Francesco Pepe, Omshree Shetty, Silvia Calabuig Farinas, Simon Heeke, Julia V. Burnier, Simon J. Patton, Ellen Heitzer, Giovanni Nigita, Paul Hofman, Maria Jose Serrano, Massimo Cristofanilli, Eloisa Jantus-Lewintre, David R. Gandara, Christian Rolfo, Umberto Malapelle
Format:	Article
Language:	English
Published:	Elsevier 2025-06-01
Subjects:	Circulating tumor DNA (ctDNA) Precision oncology Standardization Quality assurance Liquid biopsy
Online Access:	http://www.sciencedirect.com/science/article/pii/S2950195425000177